Teledentistry Leader MouthWatch Appoints TeleDent ™ COVID-19 Advisory Board

Advisors Will Provide Guidance on Teledentistry-Delivered Urgent Careand Expanding Teledentistry Beyond the Coronavirus Pandemic  Metuchen, NJ – April 2, 2020 – MouthWatch, LLC recently announced the formation of a TeleDent COVID-19 Advisory Board. This group of teledentistry thought leaders will help MouthWatch develop best practice protocols for implementing teledentistry in the new reality of urgent care only. The team will also ass ist the company with creating very timely teledentistry-focused education and training materials. Topics covered will include the following:Establishing Oral Triage ProtocolsImplementing Proper CodingCoordinating Dental Team ParticipationDeveloping Virtual WorkflowsConducting Live ConsultationsExplaining Legal&Regulatory ParametersAccording to MouthWatch CEO and Founder, Brant Herman, “Many care providers are trying to figure out how to properly implement teledentistry so they can deliver urgent patient care. Our goal is to fill this information gap and to also ensure that teledentistry adoption and utilization continues long after the pandemic is over. I’m confident that we have the right advisory board in place to help us achieve these goals.”The TeleDent COVID-19 Advisory Board consists of the following teledentistry thought leaders:Margaret Scarlett DMD is an infectious and chronic disease prevention specialist, dentist and author.  For thirty years, Dr. Scarlett has provided expert guidance ...
Source: Dental Technology Blog - Category: Dentistry Source Type: news

Related Links:

Danger. Deprivation. Xenophobia. Contamination. These are some of the fears related to COVID-19. Scores ofCOVID questionnaires have popped up recently to assess fear, anxiety, stress, and depression related to the novel coronavirus and its massive disruption to daily life. Most are freely available for use as research tools, but few have been validated and peer reviewed.The COVID Stress Scales (CSS) developed byTaylor and colleagues (2020) were recently published in theJournal of Anxiety Disorders. The authors propose a new COVID Stress Syndrome, and present evidence that the CSS subscales are intercorrelated (which is sug...
Source: The Neurocritic - Category: Neuroscience Authors: Source Type: blogs
The novel coronavirus (SARS-CoV-2) that arose in China in December 2019 resulted in an epidemic that quickly expanded with particular intensity in the United States and European countries, particularly Italy and Spain, devastating the foundations of our nations in one of the most significant public health threats of our time. Sadly, this disease has spread globally, and from March 12 on, the American Society for Reproductive Medicine and European Society of Human Reproduction and Embryology made similarly cautious recommendations on managing patients who were undergoing infertility therapy or desiring pregnancy, but withou...
Source: Fertility and Sterility - Category: Reproduction Medicine Authors: Tags: Inklings Source Type: research
America ’s decades-long relationship with the organization has been instrumental in improving health around the world.
Source: NYT Health - Category: Consumer Health News Authors: Tags: Coronavirus (2019-nCoV) World Health Organization Presidential Election of 2020 United States Politics and Government Epidemics Centers for Disease Control and Prevention League of Nations Trump, Donald J Henderson, Donald A Frieden, Tho Source Type: news
We appreciate the feedback and thoughtful discussion offered by Dr Hai and colleagues. We are pleased our paper is generating meaningful conversations as we all move through this uncharted territory of ethical conundrums created by the COVID-19 pandemic. As Dr Hai and colleagues point out, we are certainly aware of the differences between the HIV/AIDS epidemic of the 1980s/1990s and the current COVID-19 pandemic. The COVID-19 pandemic exceeds what any of us have seen, and therefore requires learning from all similar healthcare crises in history.
Source: Journal of the American College of Surgeons - Category: Surgery Authors: Tags: Letter Source Type: research
When Eric Freeland, 34, started coughing at the end of March, he didn’t think much of it. But when his symptoms grew worse, Freeland’s mother began to worry. Freeland is a Native American living with his family in the Navajo Nation in the southwestern U.S., where access to healthcare is limited. He is also diabetic, putting him at greater risk to the coronavirus. When Freeland’s breathing became short and stuttered, his mother drove him to the nearest hospital where within minutes of arriving, he lost consciousness. He awoke three weeks later, hooked up to a ventilator, from a medically induced coma. &l...
Source: TIME: Health - Category: Consumer Health News Authors: Tags: Uncategorized COVID-19 feature Londontime Source Type: news
Discussions with the FDA are ongoing to define the required data set for filing Janssen’s Ebola vaccine regimen under the FDA’s Animal Rule licensure pathway. About Janssen’s Ebola Vaccine Regimen The Janssen investigational preventive Ebola vaccine regimen (Ad26.ZEBOV, MVA-BN-Filo) utilizes a viral vector strategy in which viruses – in this case adenovirus serotype 26 (Ad26) and Modified Vaccinia Virus Ankara (MVA) – are genetically modified so that they cannot replicate in human cells. In addition, these vectors are modified to safely carry the genetic code of an Ebola virus protein in order...
Source: Johnson and Johnson - Category: Pharmaceuticals Tags: Innovation Source Type: news
THE CORONAVIRUS DISEASE 2019 (COVID-19) outbreak that spread from Wuhan, China, in December 2019 became a global pandemic within about 2 months, causing more than 330,000 deaths worldwide so far (at the time of writing).1 This has forced hospitals in the most affected countries and regions around the world to rearrange their activity, creating new spaces and pathways while reducing nonurgent admissions and health services.2 Although only a minority of patients infected with the new severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) develop symptoms severe enough to require intensive care unit (ICU) admission,3 th...
Source: Journal of Cardiothoracic and Vascular Anesthesia - Category: Anesthesiology Authors: Tags: Editorial Source Type: research
As nations around the world scramble to bring coronavirus outbreaks under control, Dr. Raj Panjabi is worried that the world’s poor populations will be excluded from accessing treatments and prevention measures, a scenario he calls “viral apartheid.” “I don’t use that term lightly,” said Panjabi, speaking with TIME Senior Writer Alice Park during a TIME 100 Talks discussion on May 28. “The idea that a group of people—whether it’s the vaccines, the test or treatments—will get access to those vital life-saving tools, and that those will likely be the rich nations an...
Source: TIME: Health - Category: Consumer Health News Authors: Tags: Uncategorized COVID-19 TIME100 Talks Source Type: news
COVID-19 is caused by the Severe Acute Respiratory Syndrome (SARS) coronavirus (Cov)-2, an enveloped virus with a positive-polarity, single-stranded RNA genome. The initial outbreak of the pandemic began in December 2019, and it is affecting the human health of the global community. In common with previous pandemics (Influenza H1N1 and SARS-CoV) and the epidemics of Middle east respiratory syndrome (MERS)-CoV, CoVs target bronchial and alveolar epithelial cells. Virus protein ligands (e.g., haemagglutinin or trimeric spike glycoprotein for Influenza and CoV, respectively) interact with cellular receptors, such as (dependin...
Source: Frontiers in Immunology - Category: Allergy & Immunology Source Type: research
Yehua Shen, Chien-shan Cheng, Peng Wang, Xu Zhu, Guangyan Lei, Yong Fang, Hailiang Li, Weijun Fan, Hongming Pan, Zhe Tang, Kuansheng Ma, Xiaoguang Li, Zhengyu Lin, Yiping Zhuang, Xin Ye, Bo Zhai, Yue Han, Jinhua Huang, Huixiong Xu, Rongqin Zheng, Rufu Chen, Jie Yu, Dong Xu, Zhongmin Wang, Zhiqiang MengJournal of Cancer Research and Therapeutics 2020 16(2):350-355 The coronavirus disease 2019 (COVID-19) has become a global pandemic since its outbreak in December 2019, which posed a threat to the safety and well-being of people on a global scale. Cancer patients are at high risk of severe acute respiratory syndrome coronavi...
Source: Journal of Cancer Research and Therapeutics - Category: Cancer & Oncology Authors: Source Type: research
More News: American Health | Blogging | Centers for Disease Control and Prevention (CDC) | Coronavirus | COVID-19 | Dentistry | Education | Emergency Medicine | Epidemics | Epidemiology | Infectious Diseases | International Medicine & Public Health | Learning | Legislation | Pandemics | Podcasts | Students | Training | Universities & Medical Training | USA Health